Ajooni Biotech

Ajooni Biotech Equity

The The Equity of Ajooni Biotech (AJOONI.NS) as of Oct 19, 2026 is 911.92 M INR. In the previous year, The Equity was 880.79 M INR — a change of 3.53% (higher).

Equity

911.92 MINR

YoY

3.53%

Last updated:

In 2026, Ajooni Biotech's equity was 911.92 M INR, a 3.53% increase from the 880.79 M INR equity in the previous year.

The Ajooni Biotech Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
121.65 M INR
Jan 1, 2020
158.91 M INR
Jan 1, 2021
156.51 M INR
Jan 1, 2022
163.82 M INR
Jan 1, 2023
416.69 M INR
Jan 1, 2024
427.09 M INR
Jan 1, 2025
880.79 M INR
Jan 1, 2026
911.92 M INR
The Ajooni Biotech Equity history
YEAREquityYoY
911.92 MINR+3.53%
880.79 MINR+106.23%
427.09 MINR+2.49%
416.69 MINR+154.35%
163.82 MINR+4.67%
156.51 MINR-1.51%
158.91 MINR+30.63%
121.65 MINR+11.16%
109.44 MINR+1,028.79%
9.70 MINR+85.80%
5.22 MINR+22.72%
4.25 MINR+20.62%
3.53 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ajooni Biotech Stock analysis

What does Ajooni Biotech do? Ajooni Biotech Ltd, listed on the National Stock Exchange of India with ticker AJOONI.NS and ISIN INE820Y01021, is a company operating in the Consumer Staples sector, specifically within the Food Products industry. Headquartered in Mohali, Punjab, the company went public through an IPO on January 2, 2018. Ajooni Biotech focuses on the manufacturing, production, processing, and supply of cattle feed nutrients and animal health care supplements. The company offers a variety of products including compounded animal feed and feed supplements designed to support the entire life cycle of animals. Its product range encompasses cattle feed, cattle feed chips, camel feed, cotton oil cake, and mustard oil cake. The firm provides high-energy balanced cattle feed formulations such as calf starter, heifer, dairy calf grower, low yield cattle, basic milking cattle, and high yield cattle feeds. Specific product names mentioned include Autus DIAMOND WONDER, Autus NURTURE CALF STARTER, Autus WINNER, Autus HIFFER/GROWER, Autus ENERGY PLUS, Autus ECO, and Autus BUFF POWER. Additionally, the company supplies feed supplements like liquid calcium, liver tonic, mineral mixture, ultra-tonic, digestive powder, and multi vitamins, as well as products such as CALTUS, 4U, LIVTUS, RUMITUS, Mustmin, and AUTOVITA. The company's website is https://www.ajoonibiotech.com/. Ajooni Biotech is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Ajooni Biotech's Equity

Ajooni Biotech's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Ajooni Biotech's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Ajooni Biotech's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Ajooni Biotech's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Ajooni Biotech’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Ajooni Biotech stock

The Equity of Ajooni Biotech is 911.92 M INR in 2026.

The Equity of Ajooni Biotech changed from 880.79 M INR to 911.92 M INR, representing a 3.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Ajooni Biotech since 2006 – with annual values, charts, and detailed analysis.

The Equity's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Ajooni Biotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Ajooni Biotech

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Ajooni Biotech